RecruitingPhase 3NCT06891950
Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)
Studying Dengue fever
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Butantan Institute
- Principal Investigator
- Fernanda C Boulos, MD, PhDInstituto Butantan
- Intervention
- Dengue 1,2,3,4 (attenuated) vaccine(biological)
- Enrollment
- 997 enrolled
- Eligibility
- 40-79 years · All sexes
- Timeline
- 2026 – 2026
Study locations (5)
- CWB 02 - Centro Médico São Francisco, Curitiba, Paraná, Brazil
- PET 01 - Hospital Escola da Universidade de Pelotas - HEUFPEL, Pelotas, Rio Grande do Sul, Brazil
- POA 05 - Núcleo de Pesquisa do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
- POA 02 - Associação Hospitalar Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil
- POA 01 - Centro de Pesquisa: Hospital São Lucas - PUCRS, Porto Alegre, Rio Grande do Sul, Brazil
Collaborators
Butantan Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06891950 on ClinicalTrials.govOther trials for Dengue fever
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07412483A Controlled Human Infection Model of DengueTan Tock Seng Hospital
- RECRUITINGPHASE3NCT06579755A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)Takeda
- RECRUITINGNCT07409857International Registry of Dengue Infection in Congenital Bleeding Disorders (DengueCBDR)Mahidol University
- ACTIVE NOT RECRUITINGPHASE3NCT07047521A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy AdultsTakeda
- ENROLLING BY INVITATIONPHASE2NCT07172100To Assess the Efficacy of Carica Papaya Leaf Extract in Improving Platelet Counts Among Pediatric Patients With Dengue-associated ThrombocytopeniaZiauddin Hospital
- RECRUITINGPHASE2NCT06551844Adaptive Dengue Antiviral Platform TrialOxford University Clinical Research Unit, Vietnam
- RECRUITINGNCT07007585Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus InfectionJose Ivan Rodriguez de Molina Serrano
- RECRUITINGPHASE3NCT06665035A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and ToddlersTakeda